Research Projects & Grants

Internal

  • Incidence of Hypertension in Patients Receiving Oral Chemotherapy in a Specialty Pharmacy Setting, Role: PI, LLU Dept. of Pharmacy Practice, (10/2023) Status: Approved
  • Evaluating the Effectiveness and Cost of Filgrastim Biosimilar at Loma Linda University Medical Center, Role: PI, LLU Dept. of Pharmacy Practice, (10/2023) Status: Approved
  • Assessment of Utilization Patterns of Novel Hormonal Therapy (NHT) Agents in Non-metastatic Prostate Cancer, Role: Investigator, LLU Dept. of Pharmacy Practice, (12/2021) Status: Approved
  • Daily Dosing of Acyclovir for Viral Infection Prophylaxis in Patients with Hematologic Malignancy, Role: PI, LLU Dept. of Pharmacy Practice, (10/2020) Status: Approved
  • Incidence and management of cardiotoxicity in patients that have received anthracycline or anti-HER2 based treatment, Role: PI, LLU Dept. of Pharmacy Practice, (12/2019 - 07/2020) Status: Completed
  • Impact of an oncology pharmacy resident-driven oral chemotherapy clinic, Role: PI, LLU Dept. of Pharmacy Practice, (02/2019 - 07/2021) Status: Completed
  • Evaluation of febrile neutropenia guideline adherence at Loma Linda University Medical Center (LLUMC ), Role: PI, LLU Dept. of Pharmacy Practice, (01/2019 - 01/2020) Status: Completed
  • Predicting the risk of chemotherapy toxicity in the elderly population, Role: PI, LLU Dept. of Pharmacy Practice, (12/2017 - 12/2018) Status: Completed
  • Partial dose of pegfilgrastim use in adult oncology patients - Does one size fits all?, Role: PI, LLU School of Pharmacy, (09/2016 - 09/2017) Status: Completed
  • Safety of new oral anticoagulants in patients with cancer within a university health system, Role: PI, LLU Dept. of Pharmacy Practice, (12/2014 - 12/2015) Status: Completed
  • Evaluation of the utilization of intravenous biphosphonates and/or denusomab for breast cancer bone metastases: a retrospective analysis, Role: PI, LLU Dept. of Pharmacy Practice, (11/2014 - 11/2015) Status: Completed
  • Retrospective chart review of CD20 and hepatitis B virus testing prior to rituximab administration, Role: PI, LLU Dept. of Pharmacotherapy and Outcomes Sciences, (01/2013) Status: Completed